These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from April 3 through April 9, 2025. Source: VerityData

Increases in Holdings

Couchbase$(BASE)$ Haveli Investments increased its stake in the cloud database company to 5,195,601 shares. Haveli Investments did so through the purchase of 990,433 Couchbase shares from March 28 through April 3, 2025, at per share prices of $14.60 to $15.96. Following the latest purchases, Haveli owns 9.8% of Couchbase's outstanding stock. Shares of Couchbase have gained roughly 3.2% since the start of 2025.

Staar Surgical$(STAA)$ Broadwood Partners increased its stake in the manufacturer of eyeglass lenses to 13,358,164 shares. Broadwood Partners did so through the purchase of 1,379,066 Staar Surgical shares from March 4 through April 7, 2025, at per share prices of $14.97 to $17.99. Following the latest purchases, Broadwood Partners owns 27.1% of Staar Surgical's outstanding stock. Shares of Staar Surgical have lost over a third of their value since the start of 2025.

Aeva Technologies$(AEVA)$ Sylebra Capital raised its stake in the autonomous sensing technology company to 16,228,553 shares. Sylebra Capital did so through the purchase of 5,849,249 Aeva shares from March 24 through March 31, 2025, at per share prices of $4.36 to $6.77. Following the latest purchases, Sylebra Capital continues to own 29.6% of Aeva's outstanding stock. Shares of Aeva have gained approximately 40.1% in value since the beginning of this year.

Mid Penn Bancorp$(MPB)$ General American Capital raised its stake in the Harrisburg, Pa.--based regional bank to 1,410,644 shares. General American did so through the purchase of 220,565 Mid Penn Bancorp shares from Jan. 7 through April 1, 2025, at per share prices of $25.62 to $30.25. Following the latest purchases, General American owns 7.3% of Mid Penn Bancorp's outstanding stock. Shares of Mid Penn Bancorp have lost about 10% in value since the start of 2025.

Zymeworks$(ZYME)$ EcoR1 Capital raised its stake in the oncology-focused biopharmaceutical company to 17,699,774 shares. EcoR1 Capital purchased 841,356 Zymeworks shares from March 18 through April 4, 2025, at per share prices of $11.17 to $13.08. Following the latest purchases, EcoR1 Capital continues to own 25.4% of Zymeworks' outstanding stock. Shares of Zymeworks have lost a third of their value since the beginning of this year.

Decreases in Holdings

Runway Growth Finance$(RWAY)$ OCM Growth Holdings lowered its stake in the specialty finance company to 9,779,668 shares. OCM Growth did so through the sale of 1,000,000 Runway Growth shares pursuant to a Rule 144 sale on April 1, 2025, at an average price of $10.35 per share. Following the latest sale, OCM Growth Holdings continues to own approximately 26.2% of Runway Growth Finance's outstanding stock. Shares of Runway Growth Finance have lost roughly 18.4% of their value since the beginning of this year.

Email: editors@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

April 11, 2025 15:07 ET (19:07 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.